STROKOG (stroke and cognition consortium): An international consortium to examine the epidemiology, diagnosis, and treatment of neurocognitive disorders in relation to cerebrovascular disease
- PMID: 28138511
- PMCID: PMC5257024
- DOI: 10.1016/j.dadm.2016.10.006
STROKOG (stroke and cognition consortium): An international consortium to examine the epidemiology, diagnosis, and treatment of neurocognitive disorders in relation to cerebrovascular disease
Abstract
Introduction: The Stroke and Cognition consortium (STROKOG) aims to facilitate a better understanding of the determinants of vascular contributions to cognitive disorders and help improve the diagnosis and treatment of vascular cognitive disorders (VCD).
Methods: Longitudinal studies with ≥75 participants who had suffered or were at risk of stroke or TIA and which evaluated cognitive function were invited to join STROKOG. The consortium will facilitate projects investigating rates and patterns of cognitive decline, risk factors for VCD, and biomarkers of vascular dementia.
Results: Currently, STROKOG includes 25 (21 published) studies, with 12,092 participants from five continents. The duration of follow-up ranges from 3 months to 21 years.
Discussion: Although data harmonization will be a key challenge, STROKOG is in a unique position to reuse and combine international cohort data and fully explore patient level characteristics and outcomes. STROKOG could potentially transform our understanding of VCD and have a worldwide impact on promoting better vascular cognitive outcomes.
Keywords: Cohort studies; Data harmonization; International consortium; Post-stroke dementia; Small vessel disease; Vascular cognitive disorder; Vascular dementia.
Similar articles
-
COSMIC (Cohort Studies of Memory in an International Consortium): an international consortium to identify risk and protective factors and biomarkers of cognitive ageing and dementia in diverse ethnic and sociocultural groups.BMC Neurol. 2013 Nov 6;13:165. doi: 10.1186/1471-2377-13-165. BMC Neurol. 2013. PMID: 24195705 Free PMC article.
-
National and international collaborations to advance research into vascular contributions to cognitive decline.Cereb Circ Cogn Behav. 2023 Dec 14;6:100195. doi: 10.1016/j.cccb.2023.100195. eCollection 2024. Cereb Circ Cogn Behav. 2023. PMID: 38226362 Free PMC article.
-
Association of Prediabetes and Type 2 Diabetes With Cognitive Function After Stroke: A STROKOG Collaboration Study.Stroke. 2020 Jun;51(6):1640-1646. doi: 10.1161/STROKEAHA.119.028428. Epub 2020 May 14. Stroke. 2020. PMID: 32404039
-
Neuropsychological assessment and cerebral vascular disease: the new standards.Rev Neurol (Paris). 2013 Oct;169(10):779-85. doi: 10.1016/j.neurol.2013.07.009. Epub 2013 Aug 30. Rev Neurol (Paris). 2013. PMID: 23999023 Review.
-
Dementia -- Caring, Ethics, Ethnical and Economical Aspects: A Systematic Review [Internet].Stockholm: Swedish Council on Health Technology Assessment (SBU); 2008 Jun. SBU Assessment No. 172. Stockholm: Swedish Council on Health Technology Assessment (SBU); 2008 Jun. SBU Assessment No. 172. PMID: 28876770 Free Books & Documents. Review.
Cited by
-
Network analysis of neuropsychiatric, cognitive, and functional complications of stroke: implications for novel treatment targets.Psychiatry Clin Neurosci. 2024 Apr;78(4):229-236. doi: 10.1111/pcn.13633. Epub 2024 Jan 29. Psychiatry Clin Neurosci. 2024. PMID: 38113307 Free PMC article.
-
Impact of Small Vessel Disease Progression on Long-term Cognitive and Functional Changes After Stroke.Neurology. 2022 Apr 5;98(14):e1459-e1469. doi: 10.1212/WNL.0000000000200005. Epub 2022 Feb 7. Neurology. 2022. PMID: 35131905 Free PMC article.
-
Safety, Tolerability, Pharmacokinetics and Initial Pharmacodynamics of a Subcommissural Organ-Spondin-Derived Peptide: A Randomized, Placebo-Controlled, Double-Blind, Single Ascending Dose First-in-Human Study.Neurol Ther. 2022 Sep;11(3):1353-1374. doi: 10.1007/s40120-022-00380-6. Epub 2022 Jul 2. Neurol Ther. 2022. PMID: 35779189 Free PMC article.
-
Vascular-brain Injury Progression after Stroke (VIPS) study: concept for understanding racial and geographic determinants of cognitive decline after stroke.J Neurol Sci. 2020 May 15;412:116754. doi: 10.1016/j.jns.2020.116754. Epub 2020 Feb 19. J Neurol Sci. 2020. PMID: 32120131 Free PMC article. Review.
-
Endovascular treatment outcomes using the Stroke Triage Education, Procedure Standardization, and Technology (STEPS-T) program.Interv Neuroradiol. 2018 Feb;24(1):51-56. doi: 10.1177/1591019917740100. Epub 2017 Nov 9. Interv Neuroradiol. 2018. PMID: 29119876 Free PMC article.
References
-
- Román G.C. Science Press; London: 2003. Managing Vascular Dementia.
-
- Lobo A., Launer L.J., Fratiglioni L., Andersen K., Di Carlo A., Breteler M.M. Prevalence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology. 2000;54:S4–S9. - PubMed
-
- Rockwood K., Wentzel C., Hachinski V., Hogan D.B., MacKnight C., McDowell I. Prevalence and outcomes of vascular cognitive impairment. Neurology. 2000;54:447–451. - PubMed
-
- Pohjasvaara T., Erkinjuntti T., Ylikoski R., Hietanen M., Vataja R., Kaste M. Clinical determinants of poststroke dementia. Stroke. 1998;29:75–81. - PubMed
-
- Sachdev P.S., Brodaty H., Valenzuela M.J., Lorentz L., Looi J.C.L., Berman K. Clinical determinants of dementia and mild cognitive impairment following ischaemic stroke: the Sydney Stroke Study. Dement Geriatr Cogn Disord. 2006;21:275–283. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources